Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers suggest that 67.3 million people are living with NAFLD in the United States and Canada.
A distinct set of microbes sets apart people with advanced fibrosis from those with minimal fibrosis.
While women have a lower risk for NAFLD, once present, the disease advanced more rapidly.
The United States isn’t alone in grappling with this growing health problem.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
Study finds people who took daily aspirin had a lower risk of NASH and advanced liver scarring.
The tool can predict whether people with fatty liver disease will develop advanced fibrosis with up to 92 percent accuracy.
However, in a small subset of those with advanced fibrosis or cirrhosis, liver damage remains the same or worsens post-cure.
A recent study compared rates of progression to decompensated cirrhosis among those who recently received hepatitis C treatment.
Individuals with advanced fibrosis or cirrhosis who are cured of hepatitis C virus (HCV) often see their liver damage reduced.
Those coinfected with hepatitis C and HIV who have advanced fibrosis should receive hep C therapy, because of the risk of developing liver dec...
The new therapy simeprevir is generally safe and well-tolerated among hep C patients with advanced liver fibrosis and improves treatment outco...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.